Likewise, the hormonal classification as a predictive marker of favourable response to endocrine therapy has not been established in canine mammary tumours, therefore, expression of hormone receptors analysis is currently not routinely assessed in canine mCA. This evidence concerns the gene NR4A1 and breast cancer.